U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907017) titled 'CorWave LVAS FIH Study' on March 21.
Brief Summary: The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAD for the treatment of advanced heart failure patients.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Heart Failure
Intervention:
DEVICE: LVAD
Implantation and use of the CorWave LVAS to evaluate the safety and effectiveness of the CorWave LVAD to treat advanced left ventricular heart failure.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: CorWave
Published by HT Digital Content Services with permission from Health Daily...